No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium.

[1]  Jeroen J. Bax,et al.  Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging? , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  J. Mattera,et al.  Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. , 1999, Circulation.

[3]  R. Štípal,et al.  Prognostic value of the amount of dysfunctional but viablemyocardium in revascularized patients with coronary arterydisease and left ventricular dysfunction , 1999 .

[4]  J. Pepper,et al.  Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. , 1998, Circulation.

[5]  R. Štípal,et al.  Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. , 1998, Journal of the American College of Cardiology.

[6]  E. Erdmann,et al.  Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. , 1998, Journal of the American College of Cardiology.

[7]  J. Townend,et al.  Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure , 1998, Heart.

[8]  J. Nuyts,et al.  PET scan predicts recovery of left ventricular function after coronary artery bypass operation. , 1997, The Annals of thoracic surgery.

[9]  M Schwaiger,et al.  Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. , 1997, Journal of the American College of Cardiology.

[10]  Jeroen J. Bax,et al.  Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. , 1997, Journal of the American College of Cardiology.

[11]  M. Verani,et al.  Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. , 1997, Circulation.

[12]  G. Beller,et al.  Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. , 1997, Circulation.

[13]  Jeroen J. Bax,et al.  Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. , 1997, Journal of the American College of Cardiology.

[14]  B J Messmer,et al.  Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  F. Van de Werf,et al.  Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. , 1997, Journal of the American College of Cardiology.

[16]  R O Bonow,et al.  Identification of viable myocardium. , 1996, Circulation.

[17]  J J Bax,et al.  Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. , 1996, Journal of the American College of Cardiology.

[18]  A Bol,et al.  Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. , 1996, Circulation.

[19]  B. Gerber,et al.  Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. , 1996, Journal of the American College of Cardiology.

[20]  W. Smith,et al.  Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. , 1996, Journal of the American College of Cardiology.

[21]  W. Martin,et al.  Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. , 1995, Journal of the American College of Cardiology.

[22]  M. Lumley,et al.  Psychosocial factors related to unrecognized acute myocardial infarction. , 1995, The American journal of cardiology.

[23]  C. Ng,et al.  Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. , 1995, The American journal of cardiology.

[24]  Y. Yonekura,et al.  Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. , 1995, Circulation.

[25]  W. Zoghbi,et al.  Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. , 1995, Circulation.

[26]  J. Pruim,et al.  Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  W. J. Maclntyre,et al.  Prognosis of Patients With Left Ventricular Dysfunction, With and Without Viable Myocardium After Myocardial Infarction: Relative Efficacy of Medical Therapy and Revascularization , 1994, Circulation.

[28]  J. Griffith,et al.  Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. , 1994, Circulation.

[29]  R Härkönen,et al.  Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. , 1994, American heart journal.

[30]  M. Phelps,et al.  Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. , 1994, The American journal of cardiology.

[31]  A. Quyyumi,et al.  Myocardial Viability in Patients With Chronic Coronary Artery Disease: Comparison of 99mTc‐Sestamibi With Thallium Reinjection and [18F]Fluorodeoxyglucose , 1994, Circulation.

[32]  U Sechtem,et al.  Regional 99mTc-methoxyisobutyl-isonitrile-uptake at rest in patients with myocardial infarcts: comparison with morphological and functional parameters obtained from gradient-echo magnetic resonance imaging. , 1994, European heart journal.

[33]  M. Schwaiger,et al.  Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. , 1994, Journal of the American College of Cardiology.

[34]  Y. Yonekura,et al.  Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. , 1993, Journal of the American College of Cardiology.

[35]  S. Kaul,et al.  Quantitative Planar Rest‐Redistribution 201 Imaging in Detection of Myocardial Viability and Prediction of Improvement in Left Ventricular Function After Coronary Bypass Surgery in Patients With Severely Depressed Left Ventricular Function , 1993, Circulation.

[36]  M. Schwaiger,et al.  Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. , 1992, Journal of the American College of Cardiology.

[37]  U. Ruotsalainen,et al.  Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  V. Dilsizian,et al.  Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. , 1990, The New England journal of medicine.

[39]  P. Rigo,et al.  Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. , 1990, Journal of the American College of Cardiology.

[40]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[41]  I. Goel,et al.  Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting. , 1983, The American journal of cardiology.